Tech Investors

The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society is an equity investor that backs tech companies raising capital.

Venture Investor Overview

Contact Information

Background Information

Overview

The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/13/2022

Transaction History

Our records indicate that The Leukemia & Lymphoma Society invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Louis DeGennaro

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

The Leukemia & Lymphoma Society has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more tech investors:

The LAO | The Mark Foundation for Cancer Research

Share this article

About Our Tech Company Investor Database

This tech investing database comes via a partnership with VentureDeal.com, a leading provider of tech investor transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary